PhRMA sues Trump admin over Medicare drug price pilot tied to foreign benchmarks

PhRMA filed suit against the Trump administration's pilot program that would tie Medicare drug prices to lower rates in peer countries. The lawsuit challenges the legality of the policy, which represents a direct confrontation between industry and the executive branch. The outcome could reshape U.S. drug pricing and affect pharmaceutical revenues.